|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pusztaszeri M and Auger M: Update on the
cytologic features of papillary thyroid carcinoma variants. Diagn
Cytopathol. 45:714–730. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liyanarachchi S, Li W, Yan P, Bundschuh R,
Brock P, Senter L, Ringel MD, de la Chapelle A and He H:
Genome-wide expression screening discloses long noncoding RNAs
involved in thyroid carcinogenesis. J Clin Endocrinol Metab.
101:4005–4013. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen W, Zheng R, Zeng H, Zhang S and He J:
Annual report on status of cancer in China, 2011. Chin J Cancer
Res. 27:2–12. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Roman BR, Morris LG and Davies L: The
thyroid cancer epidemic, 2017 perspective. Curr Opin Endocrinol
Diabetes Obes. 24:332–336. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Karadaghy OA, Kallogjeri D and Piccirillo
JF: Development of a new clinical severity staging system for
patients with nonmetastatic papillary thyroid carcinoma. JAMA
Otolaryngol Head Neck Surg. 143:1173–1180. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Grogan RH, Kaplan SP, Cao H, Weiss RE,
Degroot LJ, Simon CA, Embia OM, Angelos P, Kaplan EL and Schechter
RB: A study of recurrence and death from papillary thyroid cancer
with 27 years of median follow-up. Surgery. 154:1436–1447. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Giordano TJ, Kuick R, Thomas DG, Misek DE,
Vinco M, Sanders D, Zhu Z, Ciampi R, Roh M, Shedden K, et al:
Molecular classification of papillary thyroid carcinoma: Distinct
BRAF, RAS, and RET/PTC mutation-specific gene expression profiles
discovered by DNA microarray analysis. Oncogene. 24:6646–6656.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Adeniran AJ, Zhu Z, Gandhi M, Steward DL,
Fidler JP, Giordano TJ, Biddinger PW and Nikiforov YE: Correlation
between genetic alterations and microscopic features, clinical
manifestations, and prognostic characteristics of thyroid papillary
carcinomas. Am J Surg Pathol. 30:216–222. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Greco A, Miranda C and Pierotti MA:
Rearrangements of NTRK1 gene in papillary thyroid carcinoma. Mol
Cell Endocrinol. 321:44–49. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ellis RJ, Wang Y, Stevenson HS, Boufraqech
M, Patel D, Nilubol N, Davis S, Edelman DC, Merino MJ, He M, et al:
Genome-wide methylation patterns in papillary thyroid cancer are
distinct based on histological subtype and tumor genotype. J Clin
Endocrinol Metab. 99:E329–E337. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Murugan AK, Munirajan AK and Alzahrani AS:
Long noncoding RNAs: Emerging players in thyroid cancer
pathogenesis. Endocr Relat Cancer. 25:R59–R82. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sui F, Ji M and Hou P: Long non-coding
RNAs in thyroid cancer: Biological functions and clinical
significance. Mol Cell Endocrinol. 469:11–22. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wei MM and Zhou GB: Long Non-coding RNAs
and their roles in Non-small-cell lung cancer. Genomics Proteomics
Bioinformatics. 14:280–288. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bartonicek N, Maag JL and Dinger ME: Long
noncoding RNAs in cancer: Mechanisms of action and technological
advancements. Mol Cancer. 15:432016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li JH, Zhang SQ, Qiu XG, Zhang SJ, Zheng
SH and Zhang DH: Long non-coding RNA NEAT1 promotes malignant
progression of thyroid carcinoma by regulating miRNA-214. Int J
Oncol. 50:708–716. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim D, Lee WK, Jeong S, Seol MY, Kim H,
Kim KS, Lee EJ, Lee J and Jo YS: Upregulation of long noncoding RNA
LOC100507661 promotes tumor aggressiveness in thyroid cancer. Mol
Cell Endocrinol. 431:36–45. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang T, Zhai H, Yan R, Zhou Z, Gao L and
Wang L: lncRNA CCAT1 promotes cell proliferation, migration, and
invasion by down-regulation of miR-143 in FTC-133 thyroid carcinoma
cell line. Braz J Med Biol Res. 51:e70462018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dai W, Tian Y, Jiang B and Chen W:
Down-regulation of long non-coding RNA AFAP1-AS1 inhibits tumor
growth, promotes apoptosis and decreases metastasis in thyroid
cancer. Biomed Pharmacother. 99:191–197. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zheng H, Wang M, Jiang L, Chu H, Hu J,
Ning J, Li B, Wang D and Xu J: BRAF-activated long noncoding RNA
modulates papillary thyroid carcinoma cell proliferation through
regulating thyroid stimulating hormone receptor. Cancer Res Treat.
48:698–707. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang C, Yan G, Zhang Y, Jia X and Bu P:
Long non-coding RNA MEG3 suppresses migration and invasion of
thyroid carcinoma by targeting of Rac1. Neoplasma. 62:541–549.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ma B, Liao T, Wen D, Dong C, Zhou L, Yang
S, Wang Y and Ji Q: Corrigendum: Long intergenic non-coding RNA 271
is predictive of a poorer prognosis of papillary thyroid cancer.
Sci Rep. 7:423212017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lan X, Sun W, Dong W, Wang Z, Zhang T, He
L and Zhang H: Downregulation of long noncoding RNA H19 contributes
to the proliferation and migration of papillary thyroid carcinoma.
Gene. 646:98–105. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu L, Yang J, Zhu X, Li D, Lv Z and Zhang
X: Long noncoding RNA H19 competitively binds miR-17-5p to regulate
YES1 expression in thyroid cancer. FEBS J. 283:2326–2339. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tam S, Boonsripitayanon M, Amit M, Fellman
BM, Li Y, Busaidy NL, Cabanillas ME, Dadu R, Sherman S, Waguespack
SG, et al: Survival in differentiated thyroid cancer: Comparing the
AJCC cancer staging seventh and eighth editions. Thyroid.
28:1301–1310. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: Limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Szklarczyk D, Franceschini A, Kuhn M,
Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork
P, et al: The STRING database in 2011: Functional interaction
networks of proteins, globally integrated and scored. Nucleic Acids
Res. 39:D561–D568. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Smoot ME, Ono K, Ruscheinski J, Wang PL
and Ideker T: Cytoscape 2.8: New features for data integration and
network visualization. Bioinformatics. 27:431–432. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gene Ontology Consortium: Gene ontology
consortium: Going forward. Nucleic Acids Res. 43:D1049–D1056. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kanehisa M, Sato Y, Kawashima M, Furumichi
M and Tanabe M: KEGG as a reference resource for gene and protein
annotation. Nucleic Acids Res. 44:D457–D462. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dennis G Jr, Sherman BT, Hosack DA, Yang
J, Gao W, Lane HC and Lempicki RA: DAVID: Database for annotation,
visualization, and integrated discovery. Genome Biol. 4:P32003.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ogluszka M, Orzechowska M, Jedroszka D,
Witas P and Bednarek AK: Evaluate cutpoints: Adaptable continuous
data distribution system for determining survival in Kaplan-Meier
estimator. Comput Methods Programs Biomed. 177:133–139. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kartsonaki C: Survival analysis. Diagnos
Histopathol. 22:263–270. 2016. View Article : Google Scholar
|
|
35
|
Song B, Li R, Zuo Z, Tan J, Liu L, Ding D,
Lu Y and Hou D: LncRNA ENST00000539653 acts as an oncogenic factor
via MAPK signalling in papillary thyroid cancer. BMC Cancer.
19:2972019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xing M, Alzahrani AS, Carson KA, Viola D,
Elisei R, Bendlova B, Yip L, Mian C, Vianello F, Tuttle RM, et al:
Association between BRAF V600E mutation and mortality in patients
with papillary thyroid cancer. JAMA. 309:1493–1501. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Moon S, Song YS, Kim YA, Lim JA, Cho SW,
Moon JH, Hahn S, Park DJ and Park YJ: Effects of coexistent
BRAF(V600E) and TERT promoter mutations on poor clinical outcomes
in papillary thyroid cancer: A Meta-analysis. Thyroid. 27:651–660.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fahiminiya S, de Kock L and Foulkes WD:
Biologic and clinical perspectives on thyroid cancer. N Engl J Med.
375:2306–2307. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xing M: Molecular pathogenesis and
mechanisms of thyroid cancer. Nat Rev Cancer. 13:184–199. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xie J, Fan Y and Zhang X: Molecular
mechanisms in differentiated thyroid cancer. Front Biosci (Landmark
Ed). 21:119–129. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sun Y, Liu WZ, Liu T, Feng X, Yang N and
Zhou HF: Signaling pathway of MAPK/ERK in cell proliferation,
differentiation, migration, senescence and apoptosis. J Recept
Signal Transduct Res. 35:600–604. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Faustino A, Couto JP, Populo H, Rocha AS,
Pardal F, Cameselle-Teijeiro JM, Lopes JM, Sobrinho-Simões M and
Soares P: mTOR pathway overactivation in BRAF mutated papillary
thyroid carcinoma. J Clin Endocrinol Metab. 97:E1139–E1149. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Rusinek D, Swierniak M, Chmielik E, Kowal
M, Kowalska M, Cyplinska R, Czarniecka A, Piglowski W, Korfanty J,
Chekan M, et al: BRAFV600E-associated gene expression profile:
Early changes in the transcriptome, based on a transgenic mouse
model of papillary thyroid carcinoma. PLoS One. 10:e01436882015.
View Article : Google Scholar : PubMed/NCBI
|
